The global Idiopathic Pulmonary Fibrosis (IDF) treatment market size was USD 3.51 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.2% during the forecast period. Increasing Research & Development (R&D) activities and rapid technological advancements in pulmonary fibrosis are key factors driving market revenue growth.
The research report on the Idiopathic...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek